After completing amphotericin B treatment for a cryptococcal infection, a man with HIV infection is placed on a drug to prevent relapse of his fungal infection. Which pharmacologic property is associated with this drug?
(A) poor oral bioavailability
(B) low cerebrospinal fluid concentrations
(C) primarily excreted in the bile
(D) long elimination half-life
(E) must be given parenterally